Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #21 to #270.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  2. Equivalent dose‏‎ (11 revisions)
  3. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  4. Air-kerma rate constant‏‎ (9 revisions)
  5. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  6. Absorbed dose‏‎ (9 revisions)
  7. Objectives of Radiological Protection‏‎ (9 revisions)
  8. Organ/tissue absorbed dose‏‎ (8 revisions)
  9. Beneficence‏‎ (8 revisions)
  10. Prudence‏‎ (8 revisions)
  11. Effects of Exposure‏‎ (8 revisions)
  12. Collective effective dose‏‎ (7 revisions)
  13. ICRPædia Guides‏‎ (6 revisions)
  14. Exposure Categories and Situations‏‎ (6 revisions)
  15. Justice‏‎ (6 revisions)
  16. Alimentary tract‏‎ (6 revisions)
  17. Linear energy transfer‏‎ (6 revisions)
  18. Accelerated fractionation‏‎ (6 revisions)
  19. Investigation level‏‎ (6 revisions)
  20. Principle of optimisation‏‎ (5 revisions)
  21. Air-kerma, entrance surface‏‎ (5 revisions)
  22. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  23. Dose coefficient‏‎ (5 revisions)
  24. Justification‏‎ (5 revisions)
  25. Protection quantities‏‎ (5 revisions)
  26. Kerma‏‎ (5 revisions)
  27. Types of materials‏‎ (5 revisions)
  28. Radiation weighting factor‏‎ (5 revisions)
  29. Absorbed fraction‏‎ (5 revisions)
  30. Sources of Radiation Exposure‏‎ (5 revisions)
  31. Quality factor‏‎ (5 revisions)
  32. Diagnostic reference level‏‎ (4 revisions)
  33. S coefficient (radiation weighted)‏‎ (4 revisions)
  34. Non-maleficence‏‎ (4 revisions)
  35. Air-kerma, product‏‎ (4 revisions)
  36. Mass median diameter‏‎ (4 revisions)
  37. Fractionation sensitivity‏‎ (4 revisions)
  38. Programmed cell death‏‎ (4 revisions)
  39. Math‏‎ (4 revisions)
  40. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  41. High linear energy transfer radiation‏‎ (4 revisions)
  42. Bioassay‏‎ (4 revisions)
  43. Calculating Radon Doses‏‎ (4 revisions)
  44. Computed tomography dose index‏‎ (4 revisions)
  45. Direct bioassay‏‎ (4 revisions - redirect page)
  46. Protective action‏‎ (4 revisions)
  47. Reference Animal and Plant‏‎ (4 revisions)
  48. Kp index‏‎ (4 revisions)
  49. Alpha decay‏‎ (4 revisions)
  50. Effective charge number‏‎ (4 revisions)
  51. Source-related assessment‏‎ (4 revisions)
  52. Reference bioassay function‏‎ (4 revisions)
  53. Risk‏‎ (4 revisions)
  54. Senescence‏‎ (4 revisions)
  55. Averted dose‏‎ (4 revisions)
  56. Effective half-life‏‎ (4 revisions)
  57. Optimisation‏‎ (4 revisions)
  58. ICRP‏‎ (4 revisions)
  59. Sievert‏‎ (4 revisions)
  60. Forbiddenness‏‎ (4 revisions)
  61. Aerodynamic diameter‏‎ (4 revisions)
  62. Dose per content function‏‎ (3 revisions)
  63. Iso-effect plots‏‎ (3 revisions)
  64. Lifetime risk estimates‏‎ (3 revisions)
  65. Equity‏‎ (3 revisions)
  66. Virtue ethics‏‎ (3 revisions)
  67. Graded approach‏‎ (3 revisions)
  68. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  69. Isomers‏‎ (3 revisions)
  70. Fractionation‏‎ (3 revisions)
  71. Voxel phantom‏‎ (3 revisions)
  72. Organ dose equivalent‏‎ (3 revisions)
  73. Active (red) bone marrow‏‎ (3 revisions)
  74. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  75. Coster-Kronig transition‏‎ (3 revisions)
  76. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  77. Recovery‏‎ (3 revisions)
  78. Spread-out Bragg peak‏‎ (3 revisions)
  79. Emergency preparedness‏‎ (3 revisions)
  80. Gray‏‎ (3 revisions)
  81. Auger transition‏‎ (3 revisions)
  82. Bystander effect‏‎ (3 revisions)
  83. Emergency procedures‏‎ (3 revisions)
  84. Absolute risk‏‎ (3 revisions)
  85. Wisdom‏‎ (3 revisions)
  86. Complex tissues‏‎ (3 revisions)
  87. Derived air concentration‏‎ (3 revisions)
  88. Dignity‏‎ (3 revisions)
  89. Employer‏‎ (3 revisions)
  90. Target region‏‎ (3 revisions)
  91. Activity median thermodynamic diameter‏‎ (3 revisions)
  92. Growth fraction‏‎ (3 revisions)
  93. Potential exposure‏‎ (3 revisions)
  94. ICRP Publication 103‏‎ (3 revisions)
  95. Excretion rate (instantaneous)‏‎ (3 revisions)
  96. Extrathoracic airways‏‎ (3 revisions)
  97. Galactic cosmic radiation‏‎ (3 revisions)
  98. Growth hormone (somatotropin)‏‎ (3 revisions)
  99. DNA damage signalling‏‎ (3 revisions)
  100. Rigidity threshold‏‎ (3 revisions)
  101. Low Earth orbit‏‎ (3 revisions)
  102. Fairness‏‎ (3 revisions)
  103. Absorption‏‎ (3 revisions)
  104. Gamma ray‏‎ (3 revisions)
  105. X ray‏‎ (3 revisions)
  106. Biomedical research volunteer‏‎ (3 revisions)
  107. Cardiomyopathy‏‎ (3 revisions)
  108. Dose equivalent‏‎ (3 revisions)
  109. Field-size effect (Volume effect)‏‎ (3 revisions)
  110. Unsealed source‏‎ (3 revisions)
  111. Gastrointestinal syndrome‏‎ (3 revisions)
  112. Xerostomia‏‎ (3 revisions)
  113. Guide to the System of Radiological Protection‏‎ (3 revisions)
  114. Autonomy‏‎ (3 revisions)
  115. Public exposure‏‎ (3 revisions)
  116. Dose limit‏‎ (3 revisions)
  117. Interphase death‏‎ (3 revisions)
  118. Test‏‎ (3 revisions)
  119. Flexible tissues‏‎ (3 revisions)
  120. Constancy test‏‎ (3 revisions)
  121. Dose‏‎ (3 revisions)
  122. Dose limits‏‎ (3 revisions)
  123. Fluence‏‎ (3 revisions)
  124. Uptake‏‎ (3 revisions)
  125. Annual dose‏‎ (3 revisions)
  126. DS02‏‎ (3 revisions)
  127. Fluoroscopically guided interventions‏‎ (3 revisions)
  128. Utilitarian ethics‏‎ (3 revisions)
  129. Operational quantity‏‎ (3 revisions)
  130. Half-life, physical‏‎ (3 revisions)
  131. Cell death‏‎ (3 revisions)
  132. Contamination‏‎ (3 revisions)
  133. Dose of record (E)‏‎ (3 revisions)
  134. Accountability‏‎ (3 revisions)
  135. Value judgement‏‎ (3 revisions)
  136. Annual limit on intake‏‎ (3 revisions)
  137. Personal dose equivalent‏‎ (3 revisions)
  138. Principle of justification‏‎ (3 revisions)
  139. Radiofrequency ablation‏‎ (3 revisions)
  140. Exponential survival curve‏‎ (3 revisions)
  141. Valvular heart disease‏‎ (3 revisions)
  142. Health Surveillance‏‎ (2 revisions)
  143. Basal cell‏‎ (2 revisions)
  144. Branching fraction‏‎ (2 revisions)
  145. Chronic exposure‏‎ (2 revisions)
  146. Radiographer‏‎ (2 revisions)
  147. Colony‏‎ (2 revisions)
  148. Cosmic Radiation in Aviation‏‎ (2 revisions)
  149. Decommissioning‏‎ (2 revisions)
  150. Representative organism (non-human biota)‏‎ (2 revisions)
  151. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  152. Dose-threshold‏‎ (2 revisions)
  153. Threshold dose for tissue reactions‏‎ (2 revisions)
  154. Magnetosphere‏‎ (2 revisions)
  155. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  156. Action Level‏‎ (2 revisions)
  157. Heliosphere‏‎ (2 revisions)
  158. Pharynx‏‎ (2 revisions)
  159. Class SR-0 gases‏‎ (2 revisions)
  160. Decontamination‏‎ (2 revisions)
  161. Representative person‏‎ (2 revisions)
  162. Diastasis‏‎ (2 revisions)
  163. Safety‏‎ (2 revisions)
  164. Dose per unit intake coefficient‏‎ (2 revisions)
  165. Specific effective energy‏‎ (2 revisions)
  166. Emergency‏‎ (2 revisions)
  167. Limitation of dose‏‎ (2 revisions)
  168. Exposure, external or internal‏‎ (2 revisions)
  169. Transmission detection system‏‎ (2 revisions)
  170. Multistage tumorigenesis‏‎ (2 revisions)
  171. Non-sphericity parameter‏‎ (2 revisions)
  172. Graft vs host disease‏‎ (2 revisions)
  173. Air-kerma, incident‏‎ (2 revisions)
  174. Procedural values‏‎ (2 revisions)
  175. Broad beam therapy irradiation technique‏‎ (2 revisions)
  176. Class SR-1 gases‏‎ (2 revisions)
  177. Committed effective dose‏‎ (2 revisions)
  178. Cost-benefit analysis‏‎ (2 revisions)
  179. Decontamination factor‏‎ (2 revisions)
  180. Reproductive integrity‏‎ (2 revisions)
  181. Safety case‏‎ (2 revisions)
  182. Slow repair‏‎ (2 revisions)
  183. Dose rate‏‎ (2 revisions)
  184. Isotropic geometry‏‎ (2 revisions)
  185. Emergency exposure situation‏‎ (2 revisions)
  186. Lineal energy‏‎ (2 revisions)
  187. Erythropoietin‏‎ (2 revisions)
  188. Thyroid blocking‏‎ (2 revisions)
  189. Exposure (in the context of inhalation)‏‎ (2 revisions)
  190. Transparency‏‎ (2 revisions)
  191. Fractionation and dose delivery patterns‏‎ (2 revisions)
  192. Waste disposal‏‎ (2 revisions)
  193. Non-targeted effects‏‎ (2 revisions)
  194. Orphan source‏‎ (2 revisions)
  195. Hierarchical tissues‏‎ (2 revisions)
  196. Area monitoring‏‎ (2 revisions)
  197. Planned exposure situation‏‎ (2 revisions)
  198. Benthic‏‎ (2 revisions)
  199. Progenitor cell‏‎ (2 revisions)
  200. Bronchial region‏‎ (2 revisions)
  201. Radiation belt‏‎ (2 revisions - redirect page)
  202. Class SR-2 gases‏‎ (2 revisions)
  203. Committed equivalent dose‏‎ (2 revisions)
  204. Reasonableness‏‎ (2 revisions)
  205. Residual dose‏‎ (2 revisions)
  206. Dichotomous‏‎ (2 revisions)
  207. Safety culture‏‎ (2 revisions)
  208. Solar cosmic radiation‏‎ (2 revisions)
  209. Inhalability‏‎ (2 revisions)
  210. Dose rate effectiveness factor‏‎ (2 revisions)
  211. Spontaneous fission‏‎ (2 revisions)
  212. Itinerant (radiation) worker‏‎ (2 revisions)
  213. Emergency plan‏‎ (2 revisions)
  214. Linear-non-threshold model‏‎ (2 revisions)
  215. Ethics‏‎ (2 revisions)
  216. ALARA‏‎ (2 revisions)
  217. Trapped particles‏‎ (2 revisions)
  218. High level waste‏‎ (2 revisions)
  219. Platelet-derived growth factor‏‎ (2 revisions)
  220. Radiation modifier‏‎ (2 revisions)
  221. Clearance‏‎ (2 revisions)
  222. Radiological protection principles‏‎ (2 revisions)
  223. Deontological Ethics‏‎ (2 revisions)
  224. Respiratory protection‏‎ (2 revisions)
  225. Differentiation‏‎ (2 revisions)
  226. Scintigraphy‏‎ (2 revisions)
  227. Solar cycle‏‎ (2 revisions)
  228. Inner bremsstrahlung‏‎ (2 revisions)
  229. Systemic model‏‎ (2 revisions)
  230. Linear-quadratic dose response model‏‎ (2 revisions)
  231. Time factor‏‎ (2 revisions)
  232. Myocardial perfusion‏‎ (2 revisions)
  233. Activity‏‎ (2 revisions)
  234. What is Radon?‏‎ (2 revisions)
  235. Oversight‏‎ (2 revisions)
  236. Beta-minus decay‏‎ (2 revisions)
  237. Projected dose‏‎ (2 revisions)
  238. Clearance level‏‎ (2 revisions)
  239. Radionuclides of natural origin‏‎ (2 revisions)
  240. Recovery (cellular or tissue)‏‎ (2 revisions)
  241. Retrievability‏‎ (2 revisions)
  242. Immune system‏‎ (2 revisions)
  243. Dose constraint‏‎ (2 revisions)
  244. Institutional control‏‎ (2 revisions)
  245. Early normal tissue responses‏‎ (2 revisions)
  246. Stakeholder‏‎ (2 revisions)
  247. Tachycardia‏‎ (2 revisions)
  248. Tissue equivalent material‏‎ (2 revisions)
  249. Myocardial stress test‏‎ (2 revisions)
  250. Beta-plus decay‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)